COMPOUNDS, COMPOSITIONS, AND METHODS
The present disclosure relates generally to LRRK2 inhibitors, or a pharmaceutically acceptable salt, deuterated analog, prodrug, tautomer, stereoisomer, or mixture of stereoisomers thereof, and methods of making and using thereof.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!